Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...
Analyst Gil Blum from Needham reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and keeping the price target at ...
We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
For our list of the worst Ark stocks to buy according to short sellers, we ranked the 110 largest holdings in Ark Invest’s Q3 ...
In other recent news, Nurix Therapeutics has been granted PRIME designation by the European Medicines Agency (EMA) for its investigational drug NX-5948, intended for the treatment of adult patients ...
BMO Capital Markets started coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report released on ...
On Wednesday, JPMorgan (NYSE:JPM) reiterated its Overweight rating and $30.00 price target on shares of Nurix Therapeutics (NASDAQ:NRIX), a biopharmaceutical company. The firm's ...